• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Highlights From Creso Pharma's Third Quarter Update

July 24, 2017

 

Earlier today, Creso Pharma Ltd. (ASX:CPH) (OTC:CRCPF) released the company's third quarter update. Unlike U.S. and Canadian companies, Australian public companies are generally not required to file complete quarterly financial statements, however they do release a quarterly update and that sometimes comes with a statement of cash flows. Without further ado, here's some highlights from Creso Pharma's third quarter update. 

 

Operational Developments

 

  • In May, Creso Pharma signed a strategic agreement with LeafCann, where LeafCann will supply Creso Pharma with GMP-compliant cannabis and/or hemp derived materials to be used in the development of Creso's pharmaceutical grade cannabis-based therapeutics for human and animal health.

  • Creso Pharma (through their Australian partner, Health House International) became the first company to successfully import medicinal cannabis products into Australia. The import consisted of a range of three cannabis oils supplied by Canadian licensed producer, CanniMed (TSX:CMED). Health House is currently distributing the oils through authorized pharmacies across Australia. 

  • Creso Pharma also signed an LOI with Swiss-based cannabis cultivator, Cannapharm AG. The agreement will grant Creso Pharma the exclusive rights to import, store, market, distribute and sell Cannapharms' medicinal cannabis products in Asia-Pacific, Central and Latin America. 

  • Going forward, the company is expecting to generate its first revenues with the launch of its hemp-based feed for companion and zoo animals by the end of the year. The company is also expecting to generate revenue from its CannaPharm medicinal cannabis products by the end of 2017. 

 

Financial Developments

 

  • During the quarter, the company's Share Purchase Plan for eligible investors closed heavily oversubscribed with the company receiving applications representing approximately $4.1 million AUD, easily surpassing the $1 million AUD maximum. This means that more people wanted to invest in shares of Creso through this program than the amount of shares that were made available. This is a sign that should the company need or want to raise equity capital in the near future, that they will likely be able to do so.

  • As of June 30th, 2017, the company's cash balance was $9.23 million AUD (~$7.31 million USD). 

  • In the third quarter, the company spent $1.725 million AUD in operating activities, including $0.47 million on research and development. 

  • In the next quarter, Creso estimates the company's total cash outflows to be $1.199 million AUD.

 

Conclusion
 
We're expanding our coverage of the rapidly growing marijuana industry in Australia. To stay up to date, be sure to subscribe to our free Australian cannabis email newsletter. Also, don't forget to connect with The Daily Marijuana Observer on Facebook, Twitter, Instagram and StockTwits

 

Now Read: Creso Pharma's June Investor Presentation and Product Update

 

D/M/O

Disclaimer
 
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.

 

 

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.